Top Markets
Coin of the day
Lytix Biopharma AS Lytix Biopharma AS

Lytix Biopharma AS

LYTIX
Kedudukan dalam Saham #24450
Based in Oslo, Norway, Lytix Biopharma ASA is a clinical-stage biotechnology... Based in Oslo, Norway, Lytix Biopharma ASA is a clinical-stage biotechnology firm dedicated to advancing innovative immunotherapies for cancer treatment. Its primary drug candidate, LTX-315, is an oncolytic molecule currently undergoing Phase II clinical trials. This therapy is formulated for intratumoral injection, aiming to provide localized treatment for solid tumors. Additionally, Lytix Biopharma is developing LTX-401, another oncolytic molecule in its preclinical phase, specifically designed to target deep-seated cancerous lesions, including those found in liver cancer. The company was established in 2003.
Harga Saham
$0.78611575
Modal Pasaran
$60.45M
Perubahan (1 hari)
0.00%
Perubahan (1 tahun)
-12.06%
Negara
NO
Perdagangan Lytix Biopharma AS (LYTIX)

Kategori

Sejarah harga saham bagi Lytix Biopharma AS (LYTIX)
Harga penutupan tertinggi: $0.83 pada 2026-08-01

Harga penutupan terendah: $1.84 pada 2021-06-01
Sejarah harga saham Lytix Biopharma AS dari 2021 hingga 2026
Prestasi harga saham tahunan
Tahun Prestasi
2026 (TTM) -4.78%
2025 65.95%
2024 18.94%
2023 -38.40%
2022 -48.20%
2021 0.00%
Harga saham bagi syarikat atau pesaing serupa
Syarikat Harga saham Perubahan 1thn% Negara
$546.40 37.47%
US
$1.05K 57.85%
NL
$118.70 -18.24%
AU
$140.43 435.58%
US
$770.19 9.84%
CH